Mabpro, a.s.
Mabpro, a.s.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours | Clear-cell metastatic renal cell carcinoma, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, adenoma, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, epithelial neoplasm, head and neck cancer, lung disorder, lung neoplasm, malignant mesothelioma, mesothelial neoplasm, mesothelioma, neoplasm, non-small cell lung carcinoma, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm, skin disorder, triple-negative breast carcinoma | Not yet recruiting | Phase 1 | 2023-03-15 | NCT05698238 |